{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:53:56Z","timestamp":1787230436261,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s40272-019-00361-7","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T12:52:39Z","timestamp":1571403159000},"page":"451-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological Prevention and Management of Postoperative Relapse in Pediatric Crohn\u2019s Disease"],"prefix":"10.1007","volume":"21","author":[{"given":"Anat","family":"Yerushalmy-Feler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2787-4096","authenticated-orcid":false,"given":"Amit","family":"Assa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"361_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MCG.0b013e318247c32f","volume":"46","author":"BP Abraham","year":"2012","unstructured":"Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012;46:581\u20139.","journal-title":"J Clin Gastroenterol"},{"key":"361_CR2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2008.06.079","volume":"135","author":"G Vernier-Massouille","year":"2008","unstructured":"Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn\u2019s disease: a population-based cohort study. Gastroenterology. 2008;135:1106\u201313.","journal-title":"Gastroenterology"},{"key":"361_CR3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.gastro.2006.02.003","volume":"130","author":"N Gupta","year":"2006","unstructured":"Gupta N, Cohen SA, Bostrom AG, et al. Risk factors for initial surgery in pediatric patients with Crohn\u2019s disease. Gastroenterology. 2006;130:1069\u201377.","journal-title":"Gastroenterology"},{"key":"361_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.amjsurg.2014.07.009","volume":"210","author":"AM Kulungowski","year":"2015","unstructured":"Kulungowski AM, Acker SN, Hoffenberg EJ, et al. Initial operative treatment of isolated ileal Crohn\u2019s disease in adolescents. Am J Surg. 2015;210:141\u20135.","journal-title":"Am J Surg"},{"key":"361_CR5","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/jgh.12967","volume":"30","author":"O Niewiadomski","year":"2015","unstructured":"Niewiadomski O, Studd C, Hair C, et al. Prospective population-based cohort of inflammatory bowel disease in the biologics era: disease course and predictors of severity. J Gastroenterol Hepatol. 2015;30:1346\u201353.","journal-title":"J Gastroenterol Hepatol"},{"key":"361_CR6","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1097\/MIB.0000000000000937","volume":"22","author":"F Rinawi","year":"2016","unstructured":"Rinawi F, Assa A, Hartman C, et al. Incidence of bowel surgery and associated risk factors in pediatric-onset Crohn\u2019s disease. Inflamm Bowel Dis. 2016;22:2917\u201323.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR7","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.jpedsurg.2017.11.060","volume":"53","author":"AL Stokes","year":"2018","unstructured":"Stokes AL, Kulaylat AN, Rocourt DV, et al. Rates and trends for inpatient surgeries in pediatric Crohn\u2019s disease in the United States from 2003 to 2012. J Pediatr Surg. 2018;53:1334\u20138.","journal-title":"J Pediatr Surg"},{"key":"361_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPG.0000000000000616","volume":"60","author":"LF Hansen","year":"2015","unstructured":"Hansen LF, Jakobsen C, Paerregaard A, et al. Surgery and postoperative recurrence in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2015;60:347\u201351.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"361_CR9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000658-200001000-00006","volume":"231","author":"O Bernell","year":"2000","unstructured":"Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn\u2019s disease. Ann Surg. 2000;231:38\u201345.","journal-title":"Ann Surg"},{"key":"361_CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ajg.2009.579","volume":"105","author":"L Peyrin-Biroulet","year":"2010","unstructured":"Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn\u2019s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289\u201397.","journal-title":"Am J Gastroenterol"},{"key":"361_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ecco-jcc\/jjw146","volume":"11","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Oh SH, Kim DY, et al. Clinical characteristics and long-term outcomes of paediatric Crohn\u2019s disease: a single-centre experience. J Crohn\u2019s Colitis. 2017;11:157\u201364.","journal-title":"J Crohn\u2019s Colitis"},{"key":"361_CR12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/apt.15094","volume":"49","author":"JJ Ashton","year":"2019","unstructured":"Ashton JJ, Borca F, Mossotto E, et al. Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood. Aliment Pharmacol Ther. 2019;49:398\u2013407.","journal-title":"Aliment Pharmacol Ther"},{"key":"361_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.12.022","author":"NE Burr","year":"2018","unstructured":"Burr NE, Lord R, Hull MA, Subramanian V. Decreasing risk of first and subsequent surgeries in patients with Crohn\u2019s disease in England from 1994 through 2013. Clin Gastroenterol Hepatol. 2018. https:\/\/doi.org\/10.1016\/j.cgh.2018.12.022 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"361_CR14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MIB.0000000000000999","volume":"23","author":"K Diederen","year":"2017","unstructured":"Diederen K, de Ridder L, van Rheenen P, et al. Complications and disease recurrence after primary ileocecal resection in pediatric Crohn\u2019s disease: a multicenter cohort analysis. Inflamm Bowel Dis. 2017;23:272\u201382.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.amjsurg.2014.06.008","volume":"208","author":"ID Bobanga","year":"2014","unstructured":"Bobanga ID, Bai S, Swanson MA, et al. Factors influencing disease recurrence after ileocolic resection in adult and pediatric onset Crohn\u2019s disease. Am J Surg. 2014;208:591\u20136.","journal-title":"Am J Surg"},{"key":"361_CR16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s11605-008-0726-1","volume":"13","author":"S Onali","year":"2009","unstructured":"Onali S, Petruzziello C, Calabrese E, et al. Frequency, pattern, and risk factors of postoperative recurrence of Crohn\u2019s disease after resection different from ileo-colonic. J Gastrointest Surg. 2009;13:246\u201352.","journal-title":"J Gastrointest Surg"},{"key":"361_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.04.045","author":"N Hammoudi","year":"2019","unstructured":"Hammoudi N, Cazals-Hatem D, Auzolle C, et al. Association between microscopic lesions at ileal resection margin and recurrence after surgery in patients with Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2019. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.045 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"361_CR18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/apt.14944","volume":"48","author":"C Auzolle","year":"2018","unstructured":"Auzolle C, Nancey S, Tran-Minh ML, et al. Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn\u2019s disease: results from a prospective cohort study. Aliment Pharmacol Ther. 2018;48:924\u201332.","journal-title":"Aliment Pharmacol Ther"},{"key":"361_CR19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","volume":"99","author":"P Rutgeerts","year":"1990","unstructured":"Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn\u2019s disease. Gastroenterology. 1990;99:956\u201363.","journal-title":"Gastroenterology"},{"key":"361_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/gut.33.3.331","volume":"33","author":"G Olaison","year":"1992","unstructured":"Olaison G, Smedh K, Sj\u00f6dahl R. Natural course of Crohn\u2019s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992;33:331\u20135.","journal-title":"Gut"},{"key":"361_CR21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gut.25.6.665","volume":"25","author":"P Rutgeerts","year":"1984","unstructured":"Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn\u2019s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665\u201372.","journal-title":"Gut"},{"key":"361_CR22","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1080\/00365520600731018","volume":"41","author":"E Landsend","year":"2006","unstructured":"Landsend E, Johnson E, Johannessen H-O, Carlsen E. Long-term outcome after intestinal resection for Crohn\u2019s disease. Scand J Gastroenterol. 2006;41:1204\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"361_CR23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jpedsurg.2015.10.078","volume":"51","author":"K Abdelaal","year":"2016","unstructured":"Abdelaal K, Jaffray B. Colonic disease site and perioperative complications predict need for later intestinal interventions following intestinal resection in pediatric Crohn\u2019s disease. J Pediatr Surg. 2016;51:272\u20136.","journal-title":"J Pediatr Surg"},{"key":"361_CR24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.dld.2016.01.009","volume":"48","author":"S Onali","year":"2016","unstructured":"Onali S, Calabrese E, Petruzziello C, Lolli E, et al. Post-operative recurrence of Crohn\u2019s disease: a prospective study at 5\u00a0years. Dig Liver Dis. 2016;48:489\u201394.","journal-title":"Dig Liver Dis"},{"key":"361_CR25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.gastro.2008.10.051","volume":"136","author":"M Regueiro","year":"2009","unstructured":"Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn\u2019s disease recurrence after ileal resection. Gastroenterology. 2009;136:441\u201350.","journal-title":"Gastroenterology"},{"key":"361_CR26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/ibd.21524","volume":"17","author":"TD Walters","year":"2011","unstructured":"Walters TD, Steinhart AH, Bernstein CN, et al. Validating Crohn\u2019s disease activity indices for use in assessing postoperative recurrence. Inflamm Bowel Dis. 2011;17:1547\u201356.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2002.31072","volume":"122","author":"WJ Sandborn","year":"2002","unstructured":"Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn\u2019s disease. Gastroenterology. 2002;122:512\u201330.","journal-title":"Gastroenterology"},{"key":"361_CR28","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cgh.2018.09.047","volume":"17","author":"P Rivi\u00e8re","year":"2019","unstructured":"Rivi\u00e8re P, Vermeire S, Irles-Depe M, et al. No change in determining Crohn\u2019s disease recurrence or need for endoscopic or surgical intervention with modification of the Rutgeerts\u2019 scoring system. Clin Gastroenterol Hepatol. 2019;17:1643\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"361_CR29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ibd.20741","volume":"15","author":"E Blum","year":"2009","unstructured":"Blum E, Katz JA. Postoperative therapy for Crohn\u2019s disease. Inflamm Bowel Dis. 2009;15:463\u201372.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2036.2008.03774.x","volume":"28","author":"M Pascua","year":"2008","unstructured":"Pascua M, Su C, Lewis JD, Brensinger C, Lichtenstein GR. Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2008;28:545\u201356.","journal-title":"Aliment Pharmacol Ther"},{"key":"361_CR31","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00384-008-0542-9","volume":"23","author":"GE Reese","year":"2008","unstructured":"Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn\u2019s disease: a meta-analysis of observational studies. Int J Colorectal Dis. 2008;23:1213\u201321.","journal-title":"Int J Colorectal Dis"},{"key":"361_CR32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1572-0241.2007.01548.x","volume":"103","author":"C Simillis","year":"2008","unstructured":"Simillis C, Yamamoto T, Reese GE, et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn\u2019s disease. Am J Gastroenterol. 2008;103:196\u2013205.","journal-title":"Am J Gastroenterol"},{"key":"361_CR33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/DCR.0b013e3181a4fa58","volume":"52","author":"RS McLeod","year":"2009","unstructured":"McLeod RS, Wolff BG, Ross S, Parkes R, McKenzie M, Investigators of the CAST Trial. Recurrence of Crohn\u2019s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum. 2009;52:919\u201327.","journal-title":"Dis Colon Rectum"},{"key":"361_CR34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ajg.2012.389","volume":"108","author":"M Lazarev","year":"2013","unstructured":"Lazarev M, Huang C, Bitton A, Cho J, Duerr R, McGovern D, et al. Relationship between proximal Crohn\u2019s disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol. 2013;108:106\u201312.","journal-title":"Am J Gastroenterol"},{"key":"361_CR35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/apt.14018","volume":"45","author":"DQ Holt","year":"2017","unstructured":"Holt DQ, Moore GT, Strauss BJ, Hamilton AL, De Cruz P, Kamm MA. Visceral adiposity predicts post-operative Crohn\u2019s disease recurrence. Aliment Pharmacol Ther. 2017;45:1255\u201364.","journal-title":"Aliment Pharmacol Ther"},{"key":"361_CR36","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(14)61908-5","volume":"385","author":"P De Cruz","year":"2015","unstructured":"De Cruz P, Kamm MA, Hamilton AL, et al. Crohn\u2019s disease management after intestinal resection: a randomised trial. Lancet. 2015;385:1406\u201317.","journal-title":"Lancet"},{"issue":"1","key":"361_CR37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ibd.21355","volume":"17","author":"M Regueiro","year":"2011","unstructured":"Regueiro M, Kip KE, Schraut W, et al. Crohn\u2019s disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis. 2011;17(1):118\u201326.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/bjs.6593","volume":"96","author":"CA Lamb","year":"2009","unstructured":"Lamb CA, Mohiuddin MK, Gicquel J, et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn\u2019s disease. Br J Surg. 2009;96:663\u201374.","journal-title":"Br J Surg"},{"key":"361_CR39","first-page":"17","volume":"10","author":"A Orlando","year":"2006","unstructured":"Orlando A, Modesto I, Castiglione F, et al. The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn\u2019s disease: a comparison with ultrasound. Eur Rev Med Pharmacol Sci. 2006;10:17\u201322.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"361_CR40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/ajg.2015.30","volume":"110","author":"G Boschetti","year":"2015","unstructured":"Boschetti G, Laidet M, Moussata D, et al. Levels of fecal calprotectin are associated with the severity of postoperative endoscopic recurrence in asymptomatic patients with Crohn\u2019s disease. Am J Gastroenterol. 2015;110:865\u201372.","journal-title":"Am J Gastroenterol"},{"key":"361_CR41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/apt.13353","volume":"42","author":"P De Cruz","year":"2015","unstructured":"De Cruz P, Kamm MA, Hamilton AL, et al. Efficacy of thiopurines and adalimumab in preventing Crohn\u2019s disease recurrence in high-risk patients\u2014a POCER study analysis. Aliment Pharmacol Ther. 2015;42:867\u201379.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"361_CR42","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/MIB.0000000000000850","volume":"22","author":"S Lopes","year":"2016","unstructured":"Lopes S, Andrade P, Afonso J, et al. Correlation between calprotectin and modified Rutgeerts score. Inflamm Bowel Dis. 2016;22(9):2173\u201381.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR43","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jpedsurg.2016.01.017","volume":"51","author":"M Hukkinen","year":"2016","unstructured":"Hukkinen M, Pakarinen MP, Merras-Salmio L, et al. Fecal calprotectin in the prediction of postoperative recurrence of Crohn\u2019s disease in children and adolescents. J Pediatr Surg. 2016;51:1467\u201372.","journal-title":"J Pediatr Surg"},{"key":"361_CR44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ibd.21003","volume":"16","author":"S Koilakou","year":"2010","unstructured":"Koilakou S, Sailer J, Peloschek P, et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn\u2019s disease after ileocolic resection. Inflamm Bowel Dis. 2010;16:198\u2013203.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR45","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/MPG.0000000000001562","volume":"64","author":"J Amil-Dias","year":"2017","unstructured":"Amil-Dias J, Kolacek S, Turner D, et al. Surgical management of Crohn disease in children: guidelines from the paediatric IBD Porto Group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2017;64:818\u201335.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"361_CR46","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"FM Ruemmele","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease. J Crohns Colitis. 2014;8:1179\u2013207.","journal-title":"J Crohns Colitis"},{"key":"361_CR47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","volume":"11","author":"P Gionchetti","year":"2017","unstructured":"Gionchetti P, Dignass A, Danese S, Magro Dias FJ, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn\u2019s Disease 2016: part 2: surgical management and special situations. J Crohns Colitis. 2017;11:135\u201349.","journal-title":"J Crohns Colitis"},{"key":"361_CR48","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0016-5085(95)90121-3","volume":"108","author":"P Rutgeerts","year":"1995","unstructured":"Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn\u2019s recurrence after ileal resection. Gastroenterology. 1995;108:1617\u201321.","journal-title":"Gastroenterology"},{"key":"361_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","author":"G Doherty","year":"2009","unstructured":"Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative recurrence of Crohn\u2019s disease. Cochrane Database Syst Rev. 2009. https:\/\/doi.org\/10.1002\/14651858 .","journal-title":"Cochrane Database Syst Rev"},{"key":"361_CR50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ecco-jcc\/jjy216","volume":"13","author":"NE Burr","year":"2019","unstructured":"Burr NE, Hall B, Hamlin PJ, Selinger CP, Ford AC, O\u2019Connor A. Systematic review and network meta-analysis medical therapies to prevent recurrence of post-operative Crohn\u2019s disease. J Crohns Colitis. 2019;13:693\u2013701.","journal-title":"J Crohns Colitis"},{"key":"361_CR51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/01.MIB.0000428910.36091.10","volume":"19","author":"HH Herfarth","year":"2013","unstructured":"Herfarth HH, Katz JA, Hanauer SB, et al. Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn\u2019s disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2013;19:1073\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","author":"M Gordon","year":"2011","unstructured":"Gordon M, Naidoo K, Thomas AG, Akobeng AK. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn\u2019s disease. Cochrane Database Syst Rev. 2011. https:\/\/doi.org\/10.1002\/14651858 .","journal-title":"Cochrane Database Syst Rev"},{"key":"361_CR53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/ajg.2010.317","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford AC, Khan KJ, Talley NJ, Moayyedi P. 5-aminosalicylates prevent relapse of Crohn\u2019s disease after surgically induced remission: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:413\u201320.","journal-title":"Am J Gastroenterol"},{"key":"361_CR54","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2004.06.002","volume":"127","author":"SB Hanauer","year":"2004","unstructured":"Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn\u2019s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004;127:723\u20139.","journal-title":"Gastroenterology"},{"key":"361_CR55","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2004.06.051","volume":"127","author":"S Ardizzone","year":"2004","unstructured":"Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn\u2019s disease. Gastroenterology. 2004;127:730\u201340.","journal-title":"Gastroenterology"},{"key":"361_CR56","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1038\/ajg.2009.301","volume":"104","author":"L Peyrin-Biroulet","year":"2009","unstructured":"Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn\u2019s disease: a meta-analysis. Am J Gastroenterol. 2009;104:2089\u201396.","journal-title":"Am J Gastroenterol"},{"key":"361_CR57","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2008.07.010","volume":"135","author":"GR D\u2019Haens","year":"2008","unstructured":"D\u2019Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn\u2019s disease: a controlled randomized trial. Gastroenterology. 2008;135:1123\u20139.","journal-title":"Gastroenterology"},{"key":"361_CR58","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/MIB.0000000000001180","volume":"23","author":"E Dom\u00e8nech","year":"2017","unstructured":"Dom\u00e8nech E, Garcia V, Iborra M, et al. Incidence and management of recurrence in patients with Crohn\u2019s disease who have undergone intestinal resection: the practicrohn study. Inflamm Bowel Dis. 2017;23:1840\u20136.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2468-1253(16)30078-4","volume":"1","author":"C Mowat","year":"2016","unstructured":"Mowat C, Arnott I, Cahill A, Smith M, Ahmad T, TOPPIC Study Group, et al. Mercaptopurine versus placebo to prevent recurrence of Crohn\u2019s disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. Lancet Gastroenterol Hepatol. 2016;1:273\u201382.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"361_CR60","first-page":"1525","volume":"55","author":"H Herfarth","year":"2006","unstructured":"Herfarth H, Tjaden C, Lukas M, Obermeier F, Dilger K, Mueller R, et al. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn\u2019s disease. Gut. 2006;55:1525\u20136.","journal-title":"Gut"},{"key":"361_CR61","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.cgh.2013.12.035","volume":"12","author":"M Regueiro","year":"2014","unstructured":"Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W. Postoperative therapy with infliximab prevents long-term Crohn\u2019s disease recurrence. Clin Gastroenterol Hepatol. 2014;12:1494\u2013502.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"361_CR62","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3748\/wjg.v18.i32.4391","volume":"18","author":"M Aguas","year":"2012","unstructured":"Aguas M, Bastida G, Cerrillo E, et al. Adalimumab in prevention of postoperative recurrence of Crohn\u2019s disease in high-risk patients. World J Gastroenterol. 2012;18:4391\u20138.","journal-title":"World J Gastroenterol"},{"key":"361_CR63","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.crohns.2012.02.012","volume":"6","author":"K Papamichael","year":"2012","unstructured":"Papamichael K, Archavlis E, Lariou C, Mantzaris GJ. Adalimumab for the prevention and\/or treatment of post-operative recurrence of Crohn\u2019s disease: a prospective, two-year, single center, pilot study. J Crohn\u2019s Colitis. 2012;6:924\u201331.","journal-title":"J Crohn\u2019s Colitis"},{"key":"361_CR64","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/archinte.167.16.1804","volume":"167","author":"D Sorrentino","year":"2007","unstructured":"Sorrentino D, Terrosu G, Avellini C, Maiero S. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med. 2007;167:1804\u20137.","journal-title":"Arch Intern Med"},{"key":"361_CR65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.dld.2014.11.005","volume":"47","author":"A Carla-Moreau","year":"2015","unstructured":"Carla-Moreau A, Paul S, Roblin X, Genin C, Peyrin-Biroulet L. Prevention and treatment of postoperative Crohn\u2019s disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials. Dig Liver Dis. 2015;47:191\u20136.","journal-title":"Dig Liver Dis"},{"key":"361_CR66","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.clinre.2015.03.007","volume":"39","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Ma T, Chen YF, et al. Biologics for the prevention of postoperative Crohn\u2019s disease recurrence: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2015;39:637\u201349.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"361_CR67","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/MEG.0000000000000178","volume":"26","author":"DL Nguyen","year":"2014","unstructured":"Nguyen DL, Solaimani P, Nguyen ET, Jamal MM, Bechtold ML. Antitumor necrosis factor \u03b1 is more effective than conventional medical therapy for the prevention of postoperative recurrence of Crohn\u2019s disease: a meta-analysis. Eur J Gastroenterol Hepatol. 2014;26:1152\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"361_CR68","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2016.02.072","volume":"150","author":"M Regueiro","year":"2016","unstructured":"Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, et al. Infliximab reduces endoscopic, but not clinical, recurrence of Crohn\u2019s disease after ileocolonic resection. Gastroenterology. 2016;150:1568\u201378.","journal-title":"Gastroenterology"},{"key":"361_CR69","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/ajg.2013.287","volume":"108","author":"E Savarino","year":"2013","unstructured":"Savarino E, Bodini G, Dulbecco P, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn\u2019s disease: a randomized controlled trial. Am J Gastroenterol. 2013;108:1731\u201342.","journal-title":"Am J Gastroenterol"},{"key":"361_CR70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.gastro.2014.09.031","volume":"148","author":"S Singh","year":"2015","unstructured":"Singh S, Garg SK, Pardi DS, Wang Z, Murad MH, Loftus EV Jr. Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn\u2019s disease after surgery: a systematic review and network meta-analysis. Gastroenterology. 2015;148:64\u201376.","journal-title":"Gastroenterology"},{"key":"361_CR71","doi-asserted-by":"crossref","first-page":"642","DOI":"10.17235\/reed.2016.4483\/2016","volume":"108","author":"CM Preda","year":"2016","unstructured":"Preda CM, Fulger LE, Negreanu L, Manuc M, Sandra I, Diculescu MM. Adalimumab versus infliximab in treating post-operative recurrence of Crohn\u2019s disease: a national cohort study. Rev Esp Enferm Dig. 2016;108:642\u20137.","journal-title":"Rev Esp Enferm Dig"},{"key":"361_CR72","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/MIB.0000000000001050","volume":"23","author":"A Assa","year":"2017","unstructured":"Assa A, Bronsky J, Kolho KL, et al. Anti-TNF\u03b1 treatment after surgical resection for Crohn\u2019s disease is effective despite previous pharmacodynamic failure. Inflamm Bowel Dis. 2017;23:791\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"361_CR73","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease. N Engl J Med. 2010;362:1383\u201395.","journal-title":"N Engl J Med"},{"key":"361_CR74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000375302","volume":"91","author":"A Sakuraba","year":"2015","unstructured":"Sakuraba A, Okamoto S, Matsuoka K, et al. Combination therapy with infliximab and thiopurine compared to infliximab monotherapy in maintaining remission of postoperative Crohn\u2019s disease. Digestion. 2015;91:233\u20138.","journal-title":"Digestion"},{"key":"361_CR75","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/ecco-jcc\/jjw152","volume":"10","author":"T Matsumoto","year":"2016","unstructured":"Matsumoto T, Motoya S, Watanabe K, Hisamatsu T, Nakase H, et al. Adalimumab monotherapy and a combination with azathioprine for Crohn\u2019s disease: a prospective, randomized trial. J Crohns Colitis. 2016;10:1259\u201366.","journal-title":"J Crohns Colitis"},{"key":"361_CR76","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10620-018-5159-4","volume":"64","author":"S Cohen-Mekelburg","year":"2019","unstructured":"Cohen-Mekelburg S, Gold S, Schneider Y, et al. Delays in initiating post-operative prophylactic biologic therapy are common among Crohn\u2019s disease patients. Dig Dis Sci. 2019;64:196\u2013203.","journal-title":"Dig Dis Sci"},{"key":"361_CR77","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0016-5085(99)70125-3","volume":"116","author":"G Hellers","year":"1999","unstructured":"Hellers G, Cortot A, Jewell D, Leijonmarck CE, Lofberg R, Malchow H, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn\u2019s disease. Gastroenterology. 1999;116:294\u2013300.","journal-title":"Gastroenterology"},{"key":"361_CR78","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00042737-199903000-00011","volume":"11","author":"K Ewe","year":"1999","unstructured":"Ewe K, Bottger T, Buhr HJ, Ecker KW, Otto HF, German Budesonide Study Group. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn\u2019s disease: a multicentre randomized placebo-controlled trial. Eur J Gastroenterol Hepatol. 1999;11:277\u201382.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"361_CR79","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2036.2010.04231.x","volume":"31","author":"GA Doherty","year":"2010","unstructured":"Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Meta-analysis: targeting the intestinal microbiota in prophylaxis for postoperative Crohn\u2019s disease. Aliment Pharmacol Ther. 2010;31:802\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"361_CR80","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.cgh.2014.10.031","volume":"13","author":"RN Fedorak","year":"2015","unstructured":"Fedorak RN, Feagan BG, Hotte N, et al. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2015;13:928\u201335.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"361_CR81","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2036.2006.03158.x","volume":"25","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn\u2019s disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther. 2007;25:67\u201372.","journal-title":"Aliment Pharmacol Ther"},{"key":"361_CR82","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018;113:481\u2013517.","journal-title":"Am J Gastroenterol"},{"key":"361_CR83","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/gut.2009.194159","volume":"59","author":"W Reinisch","year":"2010","unstructured":"Reinisch W, Angelberger S, Petritsch W, et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn\u2019s disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut. 2010;59:752\u20139.","journal-title":"Gut"},{"key":"361_CR84","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.dld.2014.07.005","volume":"46","author":"C Baudry","year":"2014","unstructured":"Baudry C, Pariente B, Louren\u00e7o N, et al. Tailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn\u2019s disease: a retrospective study. Dig Liver Dis. 2014;46:887\u201392.","journal-title":"Dig Liver Dis"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00361-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-019-00361-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00361-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:06:03Z","timestamp":1721887563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-019-00361-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s40272-019-00361-7","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]},"assertion":[{"value":"18 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was secured for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"AA: Consultation and lectures fees from AbbVie. Research grants, AbbVie and Janssen. AYF has no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}